Correlation Between AbbVie and NeuroSense Therapeutics

Can any of the company-specific risk be diversified away by investing in both AbbVie and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AbbVie Inc and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on AbbVie and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and NeuroSense Therapeutics.

Diversification Opportunities for AbbVie and NeuroSense Therapeutics

-0.41

Correlation Coefficient

AbbVie  NeuroSense Therapeutics

Very good diversification

The 3 months correlation between AbbVie and NeuroSense is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of AbbVie i.e., AbbVie and NeuroSense Therapeutics go up and down completely randomly.

Pair Corralation between AbbVie and NeuroSense Therapeutics

Given the investment horizon of 90 days AbbVie Inc is expected to under-perform the NeuroSense Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, AbbVie Inc is 16.3 times less risky than NeuroSense Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The NeuroSense Therapeutics Ltd is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  16.00  in NeuroSense Therapeutics Ltd on September 16, 2024 and sell it today you would earn a total of  9.00  from holding NeuroSense Therapeutics Ltd or generate 56.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	52.31%
Values	Daily Returns

AbbVie Inc  vs.  NeuroSense Therapeutics Ltd

AbbVie Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's fundamental drivers remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

NeuroSense Therapeutics

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with AbbVie and NeuroSense Therapeutics

The main advantage of trading using opposite AbbVie and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.

The idea behind AbbVie Inc and NeuroSense Therapeutics Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.